OTCMKTS:CHBT - China-Biotics Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About China-Biotics (OTCMKTS:CHBT)

China-Biotics, Inc. is engaged in the research, development, production, marketing, and distribution of probiotics products, which contains live microbial food supplements. It operates in two segments: retail products and bulk additive products. The Company's retail products include Shining Essence, Shining Sicanel Capsules and Probiotics Protein Powder. It manufactures and sells three categories of bulk additive products, which includes Yoghurt Culture Starter, Probotic Powder and Strains. The Company focuses on two industries in China, such as the dairy and animal feed sectors. The Company's Shining Essence composed of lactobacillus acidophilus and bifidobacterium bifidum, aimed at balancing the microecology of the human digestive system, enhancing intestinal health, and protecting and strengthening liver function. Shining Sicanel Capsules composed of lactobacillus acidophilus, focused on reducing hyperlipidemia, or excess fat in the blood.

Receive CHBT News and Ratings via Email

Sign-up to receive the latest news and ratings for CHBT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:CHBT
CUSIPN/A
WebN/A
Phone+86-21-58349748

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

China-Biotics (OTCMKTS:CHBT) Frequently Asked Questions

What is China-Biotics' stock symbol?

China-Biotics trades on the OTCMKTS under the ticker symbol "CHBT."

Has China-Biotics been receiving favorable news coverage?

News headlines about CHBT stock have been trending positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. China-Biotics earned a news sentiment score of 0.29 on Accern's scale. They also assigned press coverage about the company an impact score of 45.18 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of China-Biotics?

Shares of CHBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact China-Biotics?

China-Biotics' mailing address is Jinqiao Export Pro No.999 Ningqiao Road, Pudong District, SHANGHAI, SHA 201206, China. The company can be reached via phone at +86-21-58349748.


MarketBeat Community Rating for China-Biotics (CHBT)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  17 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  50
MarketBeat's community ratings are surveys of what our community members think about China-Biotics and other stocks. Vote "Outperform" if you believe CHBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHBT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

China-Biotics (OTCMKTS:CHBT) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/25/2016 forward)

Earnings

China-Biotics (OTCMKTS:CHBT) Earnings History and Estimates Chart

Earnings by Quarter for China-Biotics (OTCMKTS:CHBT)

China-Biotics (OTCMKTS CHBT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/14/2013Q1 2014$0.01$13.14 millionViewN/AView Earnings Details
2/9/2011$0.45$0.47ViewN/AView Earnings Details
11/9/2010Q2 2011$0.37$0.33ViewN/AView Earnings Details
8/9/2010Q1 2011$0.33$0.39ViewN/AView Earnings Details
6/11/2010Q4 2010$0.36$0.36ViewN/AView Earnings Details
2/10/2010Q3 2010$0.31$0.21ViewN/AView Earnings Details
11/17/2009Q2 2010$0.17$0.31ViewN/AView Earnings Details
8/17/2009Q1 2010$0.17$0.31ViewN/AView Earnings Details
7/15/2009Q4 2009$0.33ViewN/AView Earnings Details
2/16/2009Q3 2009$0.15ViewN/AView Earnings Details
11/10/2008Q2 2009$0.13ViewN/AView Earnings Details
8/14/2008Q1 2009$0.23ViewN/AView Earnings Details
2/13/2008Q3 2008$0.21ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

China-Biotics (OTCMKTS:CHBT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

China-Biotics (OTCMKTS CHBT) Insider Trading and Institutional Ownership History

Insider Trading History for China-Biotics (OTCMKTS:CHBT)

China-Biotics (OTCMKTS CHBT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

China-Biotics (OTCMKTS CHBT) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

China-Biotics (OTCMKTS:CHBT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

China-Biotics (OTCMKTS:CHBT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

China-Biotics (OTCMKTS CHBT) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.